BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18489386)

  • 1. Nanostructured lipid carriers as novel carrier for sunscreen formulations.
    Xia Q; Saupe A; Müller RH; Souto EB
    Int J Cosmet Sci; 2007 Dec; 29(6):473-82. PubMed ID: 18489386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
    Saupe A; Wissing SA; Lenk A; Schmidt C; Müller RH
    Biomed Mater Eng; 2005; 15(5):393-402. PubMed ID: 16179760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy.
    Saupe A; Gordon KC; Rades T
    Int J Pharm; 2006 May; 314(1):56-62. PubMed ID: 16574354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanostructured lipid carriers (NLC) on the basis of Siberian pine (Pinus sibirica) seed oil.
    Averina ES; Seewald G; Müller RH; Radnaeva LD; Popov DV
    Pharmazie; 2010 Jan; 65(1):25-31. PubMed ID: 20187575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY; Fang CL; Liu CH; Su YH
    Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
    Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
    Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
    Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
    Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations.
    Souto EB; Wissing SA; Barbosa CM; Müller RH
    Eur J Pharm Biopharm; 2004 Jul; 58(1):83-90. PubMed ID: 15207541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin moisturizing effect and skin penetration of ascorbyl palmitate entrapped in solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) incorporated into hydrogel.
    Uner M; Wissing SA; Yener G; Müller RH
    Pharmazie; 2005 Oct; 60(10):751-5. PubMed ID: 16259122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of lipid excipients in solid lipid nanoparticles.
    Radomska-Soukharev A
    Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles (SLN)--a novel carrier for UV blockers.
    Wissing SA; Müller RH
    Pharmazie; 2001 Oct; 56(10):783-6. PubMed ID: 11683123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minoxidil-loaded nanostructured lipid carriers (NLC): characterization and rheological behaviour of topical formulations.
    Silva AC; Santos D; Ferreira DC; Souto EB
    Pharmazie; 2009 Mar; 64(3):177-82. PubMed ID: 19348340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.
    Souto EB; Wissing SA; Barbosa CM; Müller RH
    Int J Pharm; 2004 Jun; 278(1):71-7. PubMed ID: 15158950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
    Teeranachaideekul V; Müller RH; Junyaprasert VB
    Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex.
    Kasongo KW; Shegokar R; Müller RH; Walker RB
    Drug Dev Ind Pharm; 2011 Apr; 37(4):396-407. PubMed ID: 20923388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin permeation of buprenorphine and its ester prodrugs from lipid nanoparticles: lipid emulsion, nanostructured lipid carriers and solid lipid nanoparticles.
    Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
    J Microencapsul; 2009 Dec; 26(8):734-47. PubMed ID: 19888882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate.
    Uner M; Wissing SA; Yener G; Müller RH
    Pharmazie; 2005 Aug; 60(8):577-82. PubMed ID: 16124399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential scanning calorimetry studies on sunscreen loaded solid lipid nanoparticles prepared by the phase inversion temperature method.
    Montenegro L; Sarpietro MG; Ottimo S; Puglisi G; Castelli F
    Int J Pharm; 2011 Aug; 415(1-2):301-6. PubMed ID: 21679757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability.
    Radomska-Soukharev A; Müller RH
    Pharmazie; 2006 May; 61(5):425-30. PubMed ID: 16724540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.